Antitrust policy in health care markets:
Health care costs in the United States are much higher than in other countries. These cost differences can be explained in part by a lack of competition in the United States. Some markets, such as pharmaceuticals and medical equipment, have elements of monopoly. Other markets, such as health insuran...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Cambridge, United Kingdom ; New York, NY
Cambridge University Press
2023
|
| Schlagworte: | |
| Online-Zugang: | BSB01 UBG01 Volltext |
| Zusammenfassung: | Health care costs in the United States are much higher than in other countries. These cost differences can be explained in part by a lack of competition in the United States. Some markets, such as pharmaceuticals and medical equipment, have elements of monopoly. Other markets, such as health insurance, have elements of monopsony. Many other markets may be subject to collusion on prices, such as generic drugs, or wages, such as the nurse labor market. Lawful monopoly and monopsony are beyond the reach of antitrust laws, but collusion is not. When appropriate, vigorous antitrust enforcement challenging anticompetitive conduct can aid in reducing health care costs. This book addresses monopoly, monopsony, cartels of sellers and buyers, horizontal and vertical merger policy, and antitrust enforcement through private suits as well as the efforts of the antitrust Agencies. The authors demonstrate how enforcing antitrust laws can ultimately promote competition and reduce health care costs |
| Beschreibung: | Title from publisher's bibliographic system (viewed on 24 Nov 2022) Health Care Markets and Competition Policy -- Antitrust Policy in the United States -- Patents and Monopoly Pricing of Pharmaceuticals -- Patents and Exclusionary Product Hopping -- Bundled Discounts and PeaceHealth -- Collusion in Health Care Markets -- Collusion in Generic Drug Markets -- The Hatch-Waxman Act, Patent Infringement Suits, and Reverse Payments -- The Alleged Insulin Conspiracy -- Licensing of Health Care Professionals -- Monopsony, Dominant Buyers, and Oligopsony -- Countervailing Power -Physician Collective Bargaining -- Group Purchasing Organizations, Monopsony, and Antitrust Policy -- Collusion in the Nurse Labor Market -- Collusion in the Oocyte Market -- No-Poaching Agreements and Antitrust Policy -- The Economics of Horizontal Mergers -- Horizontal Merger Policy -- The Economic Theory of Vertical Integration -- Vertical Merger Policy |
| Beschreibung: | 1 Online-Ressource (xxv, 502 Seiten) |
| ISBN: | 9781009099615 |
| DOI: | 10.1017/9781009099615 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV048675760 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 230125s2022 |||| o||u| ||||||eng d | ||
| 020 | |a 9781009099615 |c Online |9 978-1-00-909961-5 | ||
| 024 | 7 | |a 10.1017/9781009099615 |2 doi | |
| 035 | |a (ZDB-20-CBO)CR9781009099615 | ||
| 035 | |a (OCoLC)1369560827 | ||
| 035 | |a (DE-599)BVBBV048675760 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-473 | ||
| 082 | 0 | |a 338.4736210973 | |
| 100 | 1 | |a Angerhofer, Tirza |d 1998- |0 (DE-588)1279110929 |4 aut | |
| 245 | 1 | 0 | |a Antitrust policy in health care markets |c Tirza J. Angerhofer, Roger D. Blair, Christine Piette Durrance |
| 264 | 1 | |a Cambridge, United Kingdom ; New York, NY |b Cambridge University Press |c 2023 | |
| 300 | |a 1 Online-Ressource (xxv, 502 Seiten) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Title from publisher's bibliographic system (viewed on 24 Nov 2022) | ||
| 500 | |a Health Care Markets and Competition Policy -- Antitrust Policy in the United States -- Patents and Monopoly Pricing of Pharmaceuticals -- Patents and Exclusionary Product Hopping -- Bundled Discounts and PeaceHealth -- Collusion in Health Care Markets -- Collusion in Generic Drug Markets -- The Hatch-Waxman Act, Patent Infringement Suits, and Reverse Payments -- The Alleged Insulin Conspiracy -- Licensing of Health Care Professionals -- Monopsony, Dominant Buyers, and Oligopsony -- Countervailing Power -Physician Collective Bargaining -- Group Purchasing Organizations, Monopsony, and Antitrust Policy -- Collusion in the Nurse Labor Market -- Collusion in the Oocyte Market -- No-Poaching Agreements and Antitrust Policy -- The Economics of Horizontal Mergers -- Horizontal Merger Policy -- The Economic Theory of Vertical Integration -- Vertical Merger Policy | ||
| 520 | |a Health care costs in the United States are much higher than in other countries. These cost differences can be explained in part by a lack of competition in the United States. Some markets, such as pharmaceuticals and medical equipment, have elements of monopoly. Other markets, such as health insurance, have elements of monopsony. Many other markets may be subject to collusion on prices, such as generic drugs, or wages, such as the nurse labor market. Lawful monopoly and monopsony are beyond the reach of antitrust laws, but collusion is not. When appropriate, vigorous antitrust enforcement challenging anticompetitive conduct can aid in reducing health care costs. This book addresses monopoly, monopsony, cartels of sellers and buyers, horizontal and vertical merger policy, and antitrust enforcement through private suits as well as the efforts of the antitrust Agencies. The authors demonstrate how enforcing antitrust laws can ultimately promote competition and reduce health care costs | ||
| 650 | 4 | |a Medical economics / United States | |
| 650 | 4 | |a Antitrust law / United States | |
| 700 | 1 | |a Blair, Roger D. |d 1942- |0 (DE-588)170006166 |4 aut | |
| 700 | 1 | |a Durrance, Christine |d 1980- |0 (DE-588)1019803533 |4 aut | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 978-1-31-651520-4 |
| 856 | 4 | 0 | |u https://doi.org/10.1017/9781009099615 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-20-CBO | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-034050227 | ||
| 966 | e | |u https://doi.org/10.1017/9781009099615 |l BSB01 |p ZDB-20-CBO |q BSB_PDA_CBO |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.1017/9781009099615 |l UBG01 |p ZDB-20-CBO |q UBG_PDA_CBO |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804184845418496000 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Angerhofer, Tirza 1998- Blair, Roger D. 1942- Durrance, Christine 1980- |
| author_GND | (DE-588)1279110929 (DE-588)170006166 (DE-588)1019803533 |
| author_facet | Angerhofer, Tirza 1998- Blair, Roger D. 1942- Durrance, Christine 1980- |
| author_role | aut aut aut |
| author_sort | Angerhofer, Tirza 1998- |
| author_variant | t a ta r d b rd rdb c d cd |
| building | Verbundindex |
| bvnumber | BV048675760 |
| collection | ZDB-20-CBO |
| ctrlnum | (ZDB-20-CBO)CR9781009099615 (OCoLC)1369560827 (DE-599)BVBBV048675760 |
| dewey-full | 338.4736210973 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.4736210973 |
| dewey-search | 338.4736210973 |
| dewey-sort | 3338.4736210973 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| discipline_str_mv | Wirtschaftswissenschaften |
| doi_str_mv | 10.1017/9781009099615 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03598nmm a2200433zc 4500</leader><controlfield tag="001">BV048675760</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">230125s2022 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781009099615</subfield><subfield code="c">Online</subfield><subfield code="9">978-1-00-909961-5</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1017/9781009099615</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-20-CBO)CR9781009099615</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1369560827</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV048675760</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-473</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.4736210973</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Angerhofer, Tirza</subfield><subfield code="d">1998-</subfield><subfield code="0">(DE-588)1279110929</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Antitrust policy in health care markets</subfield><subfield code="c">Tirza J. Angerhofer, Roger D. Blair, Christine Piette Durrance</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge, United Kingdom ; New York, NY</subfield><subfield code="b">Cambridge University Press</subfield><subfield code="c">2023</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xxv, 502 Seiten)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Title from publisher's bibliographic system (viewed on 24 Nov 2022)</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Health Care Markets and Competition Policy -- Antitrust Policy in the United States -- Patents and Monopoly Pricing of Pharmaceuticals -- Patents and Exclusionary Product Hopping -- Bundled Discounts and PeaceHealth -- Collusion in Health Care Markets -- Collusion in Generic Drug Markets -- The Hatch-Waxman Act, Patent Infringement Suits, and Reverse Payments -- The Alleged Insulin Conspiracy -- Licensing of Health Care Professionals -- Monopsony, Dominant Buyers, and Oligopsony -- Countervailing Power -Physician Collective Bargaining -- Group Purchasing Organizations, Monopsony, and Antitrust Policy -- Collusion in the Nurse Labor Market -- Collusion in the Oocyte Market -- No-Poaching Agreements and Antitrust Policy -- The Economics of Horizontal Mergers -- Horizontal Merger Policy -- The Economic Theory of Vertical Integration -- Vertical Merger Policy</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Health care costs in the United States are much higher than in other countries. These cost differences can be explained in part by a lack of competition in the United States. Some markets, such as pharmaceuticals and medical equipment, have elements of monopoly. Other markets, such as health insurance, have elements of monopsony. Many other markets may be subject to collusion on prices, such as generic drugs, or wages, such as the nurse labor market. Lawful monopoly and monopsony are beyond the reach of antitrust laws, but collusion is not. When appropriate, vigorous antitrust enforcement challenging anticompetitive conduct can aid in reducing health care costs. This book addresses monopoly, monopsony, cartels of sellers and buyers, horizontal and vertical merger policy, and antitrust enforcement through private suits as well as the efforts of the antitrust Agencies. The authors demonstrate how enforcing antitrust laws can ultimately promote competition and reduce health care costs</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical economics / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antitrust law / United States</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Blair, Roger D.</subfield><subfield code="d">1942-</subfield><subfield code="0">(DE-588)170006166</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Durrance, Christine</subfield><subfield code="d">1980-</subfield><subfield code="0">(DE-588)1019803533</subfield><subfield code="4">aut</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">978-1-31-651520-4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1017/9781009099615</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-20-CBO</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-034050227</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1017/9781009099615</subfield><subfield code="l">BSB01</subfield><subfield code="p">ZDB-20-CBO</subfield><subfield code="q">BSB_PDA_CBO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1017/9781009099615</subfield><subfield code="l">UBG01</subfield><subfield code="p">ZDB-20-CBO</subfield><subfield code="q">UBG_PDA_CBO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV048675760 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T21:23:56Z |
| indexdate | 2024-07-10T09:45:47Z |
| institution | BVB |
| isbn | 9781009099615 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-034050227 |
| oclc_num | 1369560827 |
| open_access_boolean | |
| owner | DE-12 DE-473 DE-BY-UBG |
| owner_facet | DE-12 DE-473 DE-BY-UBG |
| physical | 1 Online-Ressource (xxv, 502 Seiten) |
| psigel | ZDB-20-CBO ZDB-20-CBO BSB_PDA_CBO ZDB-20-CBO UBG_PDA_CBO |
| publishDate | 2023 |
| publishDateSearch | 2022 |
| publishDateSort | 2022 |
| publisher | Cambridge University Press |
| record_format | marc |
| spelling | Angerhofer, Tirza 1998- (DE-588)1279110929 aut Antitrust policy in health care markets Tirza J. Angerhofer, Roger D. Blair, Christine Piette Durrance Cambridge, United Kingdom ; New York, NY Cambridge University Press 2023 1 Online-Ressource (xxv, 502 Seiten) txt rdacontent c rdamedia cr rdacarrier Title from publisher's bibliographic system (viewed on 24 Nov 2022) Health Care Markets and Competition Policy -- Antitrust Policy in the United States -- Patents and Monopoly Pricing of Pharmaceuticals -- Patents and Exclusionary Product Hopping -- Bundled Discounts and PeaceHealth -- Collusion in Health Care Markets -- Collusion in Generic Drug Markets -- The Hatch-Waxman Act, Patent Infringement Suits, and Reverse Payments -- The Alleged Insulin Conspiracy -- Licensing of Health Care Professionals -- Monopsony, Dominant Buyers, and Oligopsony -- Countervailing Power -Physician Collective Bargaining -- Group Purchasing Organizations, Monopsony, and Antitrust Policy -- Collusion in the Nurse Labor Market -- Collusion in the Oocyte Market -- No-Poaching Agreements and Antitrust Policy -- The Economics of Horizontal Mergers -- Horizontal Merger Policy -- The Economic Theory of Vertical Integration -- Vertical Merger Policy Health care costs in the United States are much higher than in other countries. These cost differences can be explained in part by a lack of competition in the United States. Some markets, such as pharmaceuticals and medical equipment, have elements of monopoly. Other markets, such as health insurance, have elements of monopsony. Many other markets may be subject to collusion on prices, such as generic drugs, or wages, such as the nurse labor market. Lawful monopoly and monopsony are beyond the reach of antitrust laws, but collusion is not. When appropriate, vigorous antitrust enforcement challenging anticompetitive conduct can aid in reducing health care costs. This book addresses monopoly, monopsony, cartels of sellers and buyers, horizontal and vertical merger policy, and antitrust enforcement through private suits as well as the efforts of the antitrust Agencies. The authors demonstrate how enforcing antitrust laws can ultimately promote competition and reduce health care costs Medical economics / United States Antitrust law / United States Blair, Roger D. 1942- (DE-588)170006166 aut Durrance, Christine 1980- (DE-588)1019803533 aut Erscheint auch als Druck-Ausgabe 978-1-31-651520-4 https://doi.org/10.1017/9781009099615 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Angerhofer, Tirza 1998- Blair, Roger D. 1942- Durrance, Christine 1980- Antitrust policy in health care markets Medical economics / United States Antitrust law / United States |
| title | Antitrust policy in health care markets |
| title_auth | Antitrust policy in health care markets |
| title_exact_search | Antitrust policy in health care markets |
| title_exact_search_txtP | Antitrust policy in health care markets |
| title_full | Antitrust policy in health care markets Tirza J. Angerhofer, Roger D. Blair, Christine Piette Durrance |
| title_fullStr | Antitrust policy in health care markets Tirza J. Angerhofer, Roger D. Blair, Christine Piette Durrance |
| title_full_unstemmed | Antitrust policy in health care markets Tirza J. Angerhofer, Roger D. Blair, Christine Piette Durrance |
| title_short | Antitrust policy in health care markets |
| title_sort | antitrust policy in health care markets |
| topic | Medical economics / United States Antitrust law / United States |
| topic_facet | Medical economics / United States Antitrust law / United States |
| url | https://doi.org/10.1017/9781009099615 |
| work_keys_str_mv | AT angerhofertirza antitrustpolicyinhealthcaremarkets AT blairrogerd antitrustpolicyinhealthcaremarkets AT durrancechristine antitrustpolicyinhealthcaremarkets |